Locally advanced pancreatic cancer

Journal of Clinical Oncology

Volumn 23, Issue 20, 2005, Pages 4538-4544

  Willett, Christopher G ^a   Czito, Brian G ^a   Bendell, Johanna C ^a   Ryan, David P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; DOXORUBICIN; ERLOTINIB; FLUOROURACIL; GEMCITABINE; MITOMYCIN; PACLITAXEL; PLACEBO; STREPTOZOCIN;

ADJUVANT THERAPY; ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RESEARCH; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; DUODENUM ULCER; ENDOSCOPY; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TUMOR; HUMAN; INTRAOPERATIVE RADIOTHERAPY; LAPAROSCOPY; MONOTHERAPY; MUCOSA INFLAMMATION; ORAL MUCOSITIS; PANCREAS CANCER; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; REVIEW; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STEVENS JOHNSON SYNDROME; STOMACH ULCER; THROMBOCYTOPENIA; ULTRASOUND; ADJUVANT CHEMOTHERAPY; MORTALITY; MULTIMODALITY CANCER THERAPY; PANCREAS TUMOR; PATHOLOGY; TREATMENT FAILURE;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; PANCREATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; TREATMENT FAILURE;

EID: 22844445593     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.23.911     Document Type: Review

References (44)

1. Czito B, Willett C, Clark J, et al: Chemoradiation for unresectable pancreatic cancer, in Cameron JL (ed), Pancreatic Cancer. Hamilton, Ontario, Canada, BC Decker, 2001
2. Ahmedin J, Murray J, Ward E, et al: Cancer Statistics 2005. CA Cancer J Clin 55:10-30, 2005
3. Evans DB, Abbruzzese JL, Willett CG: Cancer of the Pancreas, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer-Principles and Practice of Oncology. Philadelphia, PA, Lippincott Williams and Wilkins, 2001
4. Geer RJ, Brennan MF: Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165:68-73, 1993
5. Warshaw AL, Gu Z, Wittenberg J, et al: Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg 125:230-233, 1990
6. Brugge WR, Van Dam J: Pancreatic and biliary endoscopy. N Engl J Med 341:1808-1816, 1999
7. Shoup M, Winston C, Brennen M, et al: Is there a role for staging laparotomy in patients with locally advanced unresectable pancreatic cancer? J Gastrointest Surg 8:1068-1071, 2004
8. Fernandez-Del Castillo C, Rattner DW, Warshaw AL: Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer. Br J Surg 82:1127-1129, 1995
9. Gunderson LL, Haddock MG, Burch P, et al: Future role of radiotherapy as a component of treatment in biliopancreatic cancers. Ann Oncol 10:291-295, 1999 (suppl 4)
10. Whittington R, Solin L, Mohiuddin M, et al: Multimodality therapy of unresectable pancreatic adenocarcinoma. Cancer 54:1991-1998, 1984
11. Moertel CG, Childs DS, Reitmeier RJ, et al: Combined 5-flourouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 2:865-867, 1969
12. Moertel CG, Frytak S, Hahn RG, et al: Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-flourouracil) and high dose radiation + 5-flourouracil. Cancer 48:1705-1710, 1981
13. Gastrointestinal Tumor Study Group: Radiation therapy combined with adriamycin or 5- flourouracil for the treatment of locally unresectable pancreatic carcinoma. Cancer 56:2563-2568, 1985
14. Gastrointestinal Tumor Study Group: Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 80: 751-755, 1988
15. Klaassen DJ, MacIntyre JM, Catton GE, et al: Treatment of locally unresectable cancer of the stomach and pancreas: A randomized comparison of 5-flourouracil alone with radiation plus concurrent and maintenance 5-flourouracil-An Eastern Cooperative Oncology Group study. J Clin Oncol 3:373-378, 1985
16. O'Connell MJ, Martenson JA, Weiand HS, et al: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502-507, 1994
17. Whittington R, Neuberg D, Tester WJ, et al: Protracted intravenous fluorouracil with radiation therapy in the management of localized pancreatobiliary carcinoma: A phase I Eastern Cooperative Oncology Group trial. J Clin Oncol 13:227-232, 1995
18. Boz G, De Paoli A, Innocente R, et al: Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma. Int J Radiat Oncol Biol Phys 51:736-740, 2001
19. Osti MF, Costa AM, Bianciardi F, et al: Concomittant radiotherapy with protracted 5-fluorouracil infusion in locally advanced carcinoma of the pancreas: A phase II study. Tumori 87:398-401, 2001
20. Ben-Josef E, Shields AF, Vaishampayan U, et al: Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Int J Radiat Oncol Biol Phys 59:454-459, 2004
21. Vaishampayan UN, Ben-Josef E, Philip PA, et al: A single-insitution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies. Int J Radiat Oncol Biol Phys 53:675-679, 2002
22. Roldan GE, Gunderson LL, Nagorney DM, et al: External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer 61:1110-1116, 1988
23. Jessup JM, Steele G, Mayer RJ, et al: Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 128:559-564, 1993
24. White R, Lee C, Anscher M, et al: Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. Ann Surg Oncol 6:38-45, 1999
25. Kim HJ, Czischke K, Brennan MF, et al: Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? J Gastrointest Surg 6:763-769, 2002
26. Willett C, DelCastillo F, Goldberg S, et al: Long-term results of intraoperative electron beam radiation therapy for unresectable pancreatic cancer. Ann Surg 241:295-299, 2005
27. Burris HA, Moore MJ, Anderson J, et al: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 15:2403-2413, 1997
28. Lawrence TS, Eisbruch A, Shewach DS. Gemcitabine-mediated radiosensitization. Semin Oncol 24:S7: 24-28, 1997
29. Blackstock WA, Bernard SA, Richards F, et al: Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer. J Clin Oncol 17:2208-2212, 1999
30. Blackstock AW, Tepper JE, Niedwiecki D, et al: Cancer and Leukemia Group B (CALGB) 89805: Phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas. Int J Gastrointest Cancer 34:107-116, 2003
31. McGinn C, Zalupski MM, Shureiqi I, et al: Phase I trial of radiation dose escalation with concurrent weekly full dose gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol 19:4202-4208, 2001
32. McGinn CJ, Talamonti MS, Small W, et al: A phase II trial of full-dose gemcitabine with concurrent radiation therapy in patients with resectable or unresectable non-metastatic pancreatic cancer. ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, January 22-24, 2004 (abstr 96)
33. Talamonti MS, Catalano PF, Vaughn DH, et al: Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity. J Clin Oncol 18:3384-3389, 2000
34. Fuchs C: Unpublished data.
35. Safran H, Akerman P, Cioffi W, et al: Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach and gastroesophageal junction. Semin Radiat Oncol 9:53-57, 1999 (suppl 1)
36. Rich T, Harris J, Abrams R, et al: Phase II study of external irradiation and weekly paclitaxel for non-metastatic unresectable pancreatic cancer. Am J Clin Oncol 27:51-66, 2004
37. Termuhlen PM, Evans DB, Willett CG: IORT in pancreatic cancer, in Gunderson LL, Willett CG, Harrison LB, Calvo FA (eds): Intraoperative Irradiation-Techniques and Results. Totowa, New Jersey, Humana Press, 1999 pp 201-222
38. Haslam JB, Cavanaugh PJ, Stroup SL: Radiation therapy in the treatment of irresectable adenocarcinoma of the pancreas. Cancer 32:1341-1345, 1973
39. Dobelbower RR, Borgelt BB, Strubler KA, et al: Precision radiotherapy for cancer of the pancreas: Technique and results. Int J Radiat Oncol Biol Phys 6:1127-1133, 1980
40. Steadham AM, Liu HH, Crane CH, et al: Optimization of beam orientations and weights for coplanar conformal beams in treating pancreatic cancer. Med Dosim 24:265-271, 1999
41. Crane CH, Ellis LM, Abbruzzese JL, et al: Phase I trial of bevacizumab (BV) with concurrent radiotherapy (RT) and capecitabine (CAP) in locally advanced pancreatic adenocarcinoma (PA). Proc Am Soc Clin Oncol 23:316s, 2005 (abstr 4033)
42. Moore MJ, Goldstein D, Hamm J, et al: Erlotinib improves survival when added to gemcitabine in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group [NCIC-CTG]. ASCO Gastrointestinal Cancers Symposium, Miami, FL, January 27-29, 2005 (abstr 77)
43. Kormansky JS, O'Reilly EM, Minsky BD, et al: A phase I trial of erlotinib, gemcitabine, and radiation for patients with locally-advanced, unresectable pancreatic cancer. ASCO Gastrointestinal Cancers Symposium, Miami, FL, January 27-29, 2005 (abstr 133)
44. Iannitti D, Dipetrillo T, Barnett JM, et al: Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer: A phase I study. ASCO Gastrointestinal Cancers Symposium, Miami, FL, January 27-29, 2005 (abstr 96)